Today: 2 July 2026
Citigroup stock drops late as Citi flags $1.2 billion Q4 hit on Russia exit
30 December 2025
1 min read

Citigroup stock drops late as Citi flags $1.2 billion Q4 hit on Russia exit

NEW YORK, December 29, 2025, 18:30 ET — After-hours

  • Citigroup shares closed down 1.9% at $118.13, with the stock little changed after the bell.
  • Citi disclosed a plan to sell its remaining Russia unit, expecting a roughly $1.2 billion pre-tax loss in the fourth quarter.
  • Traders are watching this week’s Fed minutes and jobless claims ahead of Citi’s Jan. 14 earnings.

Citigroup shares fell Monday, ending down 1.9% at $118.13, after the bank disclosed it expects a roughly $1.2 billion pre-tax loss tied to its exit from Russia.

The update matters now because it lands in the current quarter’s results, weeks before Citi reports, and it puts a price tag on a long-running clean-up effort that investors have watched closely.

In an SEC filing, Citi said its board approved a plan to sell AO Citibank, which conducts its remaining operations in Russia.

Citi said it will report the Russia business as “held for sale” in the fourth quarter — an accounting label used when a company plans to dispose of an asset — and anticipates signing and closing the deal in the first half of 2026. SEC

The bank said the “held for sale” treatment would produce an estimated $1.2 billion pre-tax loss in the fourth quarter, or about $1.1 billion after tax, recorded as a reduction of “Other Revenue” through a valuation allowance. SEC

Citi also said the cumulative impact of currency translation losses recorded in the quarter, and amounts released upon closing, would be capital-neutral to its common equity tier 1 ratio (CET1, a key bank capital measure).

The filing came after Russia last month cleared Renaissance Capital to buy what remains of Citibank’s Russian operations, Reuters reported.

Citi’s decline tracked a broader retreat in bank stocks and a softer Wall Street session, with the S&P 500 down 0.35% and the Nasdaq off 0.5%, Reuters said.

Peers also finished lower, including Bank of America, Wells Fargo and Citigroup, as investors trimmed exposure late in the year.

Citi has been one of the stronger large-cap bank performers in 2025 on optimism around regulatory remediation, and the stock is up nearly 68% year-to-date, Reuters reported.

Outside banks, risk appetite was shaped by profit-taking in big technology names. “It’ll turn out to be a buying opportunity,” Hank Smith, head of investment strategy at Haverford Trust, said of the broader tech pullback. Reuters

Next up, investors will look for any additional detail on timing, regulatory approvals and foreign-exchange sensitivity around the Russia sale, which Citi said could still change the ultimate loss amount.

Citi is scheduled to publish fourth-quarter results at about 8 a.m. ET on Jan. 14, with a webcast at about 11 a.m. ET, according to a company press release.

Macro catalysts also loom: minutes from the Federal Reserve’s previous meeting and weekly jobless claims are on this week’s calendar, Reuters said — key inputs for rate expectations that can swing bank shares.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Personalis (PSNL) Jumps, Now Seen as 27% Overvalued After Rally
    July 2, 2026, 1:12 AM EDT. Personalis Inc (PSNL) soared 83.74% in the past year as new biopharma partnerships and better operations drove more clinical testing. Revenue hit $64.5 million, but net loss was $95.6 million, so profitability concerns linger. The company trades at a roughly $1.4 billion market cap after shares climbed 22.5% in the last 30 days. Analysts note the stock looks about 27% overvalued versus a $10.86 fair value, and say it needs faster revenue growth and better margins to support current prices. They flag reimbursement risk and possible equity raises as headwinds. Investors weighing gains against risk in a fast-changing healthcare AI market.
HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET
Previous Story

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop